Atalar, E. Et Al. 2022. The clinical significance of antiphospholipid antibodies in COVID-19 infection. Journal of Infection in Developing Countries , vol.16, no.2 , 276-282.

Atalar, E., Erden, A., Guven, S. C., Armagan, B., Ates, İ., KÜÇÜKŞAHİN, O., ... Omma, A.(2022). The clinical significance of antiphospholipid antibodies in COVID-19 infection. Journal of Infection in Developing Countries , vol.16, no.2, 276-282.

Atalar, Ebru Et Al. "The clinical significance of antiphospholipid antibodies in COVID-19 infection," Journal of Infection in Developing Countries , vol.16, no.2, 276-282, 2022

Atalar, Ebru Et Al. "The clinical significance of antiphospholipid antibodies in COVID-19 infection." Journal of Infection in Developing Countries , vol.16, no.2, pp.276-282, 2022

Atalar, E. Et Al. (2022) . "The clinical significance of antiphospholipid antibodies in COVID-19 infection." Journal of Infection in Developing Countries , vol.16, no.2, pp.276-282.

@article{article, author={Ebru Atalar Et Al. }, title={The clinical significance of antiphospholipid antibodies in COVID-19 infection}, journal={Journal of Infection in Developing Countries}, year=2022, pages={276-282} }